JP2017518370A5 - - Google Patents

Download PDF

Info

Publication number
JP2017518370A5
JP2017518370A5 JP2017515014A JP2017515014A JP2017518370A5 JP 2017518370 A5 JP2017518370 A5 JP 2017518370A5 JP 2017515014 A JP2017515014 A JP 2017515014A JP 2017515014 A JP2017515014 A JP 2017515014A JP 2017518370 A5 JP2017518370 A5 JP 2017518370A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
composition according
eczema
filaggrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017515014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017518370A (ja
JP6810028B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032972 external-priority patent/WO2015184134A1/en
Publication of JP2017518370A publication Critical patent/JP2017518370A/ja
Publication of JP2017518370A5 publication Critical patent/JP2017518370A5/ja
Application granted granted Critical
Publication of JP6810028B2 publication Critical patent/JP6810028B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017515014A 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置 Active JP6810028B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462005652P 2014-05-30 2014-05-30
US201462005558P 2014-05-30 2014-05-30
US62/005,558 2014-05-30
US62/005,652 2014-05-30
PCT/US2015/032972 WO2015184134A1 (en) 2014-05-30 2015-05-28 Therapeutic tratment of skin disease with recombinant commensal skin microorganisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205127A Division JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Publications (3)

Publication Number Publication Date
JP2017518370A JP2017518370A (ja) 2017-07-06
JP2017518370A5 true JP2017518370A5 (enExample) 2018-07-12
JP6810028B2 JP6810028B2 (ja) 2021-01-06

Family

ID=54699800

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017515014A Active JP6810028B2 (ja) 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Country Status (6)

Country Link
US (3) US10702558B2 (enExample)
EP (2) EP3148569B1 (enExample)
JP (2) JP6810028B2 (enExample)
ES (1) ES2929579T3 (enExample)
MA (1) MA40057A (enExample)
WO (1) WO2015184134A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10702558B2 (en) 2014-05-30 2020-07-07 Azitra Inc Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
JP2019514885A (ja) 2016-04-21 2019-06-06 ネイキッド バイオーム，インク． 皮膚障害の処置のための組成物および方法
KR20200021991A (ko) * 2017-06-16 2020-03-02 아지트라 인코포레이티드 Lekti 발현 재조합 미생물을 사용하는 네테르톤 증후군의 치료를 위한 조성물 및 방법
CN111295196A (zh) * 2017-08-31 2020-06-16 加利福尼亚大学董事会 控制皮肤酶活性的分子细菌疗法
AU2018328119B2 (en) * 2017-09-05 2025-07-10 Azitra Inc Methods and compositions for treating inflammatory skin disease with recombinant microorganisms
CA3084954A1 (en) 2017-12-05 2019-06-13 BioPlx, Inc. Methods and compositions to prevent microbial infection
JP7121969B2 (ja) * 2018-02-23 2022-08-19 株式会社北里コーポレーション 培養液保護用液状物
WO2019195714A1 (en) * 2018-04-05 2019-10-10 Azitra Inc Methods and compositions for treating skin disease with recombinant microorganisms
AU2019203692B2 (en) * 2018-08-30 2024-12-12 Kenvue Brands Llc Topical composition containing glycerin and yeast extract
WO2020069018A1 (en) * 2018-09-26 2020-04-02 Krystal Biotech, Inc. Compositions and methods for the treatment of skin diseases
WO2020076770A1 (en) * 2018-10-08 2020-04-16 Yale University Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150
EP3880241A4 (en) * 2018-11-16 2022-08-17 Azitra, Inc. AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIA
CZ308231B6 (cs) * 2019-02-11 2020-03-11 BiomCare s.r.o. Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace
EP3946412A4 (en) * 2019-04-05 2023-01-04 Azitra, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITIS WITH RECOMBINANT MICROORGANISMS
AU2020294775A1 (en) * 2019-06-19 2022-01-20 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific T-cells
KR20220133262A (ko) * 2020-01-29 2022-10-04 더 잭슨 래보라토리 박테리아 혼합물
WO2022087065A1 (en) * 2020-10-21 2022-04-28 The Jackson Laboratory Antimicrobial biosensors
AU2021416723A1 (en) * 2021-01-05 2023-07-27 L'ORéAL S.A. Strains, compositions and methods of use
EP4417684A4 (en) * 2021-10-11 2026-03-25 Ajinomoto Kk BACTERIA MODIFIED TO EXPRESS A PROTEIN TAT HETEROLOGUE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637384B2 (ja) * 1985-09-21 1994-05-18 株式会社資生堂 皮膚化粧料
US4659774A (en) 1985-11-01 1987-04-21 American Hoechst Corporation Support for solid-phase oligonucleotide synthesis
DE4221268C2 (de) 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221255C2 (de) 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
KR101802540B1 (ko) * 2009-09-25 2017-11-28 큐알엔에이, 인크. Ｆｌｇ의 발현 및 활성을 조절함으로써 필라그린(ｆｌｇ)에 관련된 질환의 치료
EP2504357B1 (en) 2009-11-23 2017-08-02 Research Development Foundation Recombinant filaggrin polypeptides for cell importation
US20130078275A1 (en) * 2010-05-25 2013-03-28 The Board Of Trustees Of The University Of Illinois Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
AU2013299605A1 (en) * 2012-08-07 2015-03-26 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
KR101491240B1 (ko) 2013-03-15 2015-02-11 현대자동차주식회사 인비저블 슬라이딩 도어 링크 구조
US10702558B2 (en) 2014-05-30 2020-07-07 Azitra Inc Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

Similar Documents

Publication Publication Date Title
JP2024009974A5 (enExample)
CN108697743B (zh) 用于治疗由痤疮丙酸杆菌引起的感染尤其是痤疮的乳酸菌的组合物
EP3849573B1 (en) Bacteriotherapy against proprionibacterium acnes for the treatment of acne
JP2016540825A5 (enExample)
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
RU2014145534A (ru) Пробиотические бактерии
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
JP2014518849A5 (enExample)
NZ627372A (en) Clostridium histolyticum enzymes and methods for the use thereof
JP2016521746A5 (enExample)
RU2018124487A (ru) Лечение внутрипеченочного холестаза и родственных заболеваний печени
JP2013136622A5 (enExample)
MA40057A (fr) Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants
Dréno The microbiome, a new target for ecobiology in dermatology
JP2014505062A5 (enExample)
JP2020524689A5 (enExample)
NZ711281A (en) Short bio-active peptides for promoting wound healing
PH12013501861A1 (en) Composition for topical use based on ozonized oil
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
EP4297765A4 (en) COMPOSITION FOR THE TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS
JP7297021B2 (ja) 乳酸菌発酵産物含有外傷外用組成物
JP2016510596A5 (enExample)
NZ629964A (en) Method for treating inflammation
CA2979079C (en) Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
CA2566776A1 (en) Method for ameliorating an inflammatory skin condition